FIVE PRIME THERAPEUTICS

five-prime-therapeutics-logo

FivePrime is dis­cov­er­ing and devel­op­ing novel ther­a­peu­tic pro­teins and anti­bod­ies by sys­tem­at­i­cally screen­ing all rel­e­vant pro­teins in the human body to find the best pro­tein for treat­ment of a given clin­i­cal indi­ca­tion. FivePrime’s Pro­Screen Engine enables the rapid pro­duc­tion and screen­ing of all ther­a­peu­ti­cally rel­e­vant pro­teins in medically-​​focused assays at the high­est qual­ity stan­dards in the indus­try. ... This pow­er­ful approach is the polar oppo­site of the industry’s tra­di­tional “one pro­tein at a time”. The Pro­Screen Engine com­prises the defin­i­tive pro­tein col­lec­tion and screen­ing process for bio­log­ics dis­cov­ery and is unprece­dented in its effi­ciency, qual­ity, and scale. In addi­tion to DBL Investors, investors include Domain Asso­ciates, Ver­sant Ven­tures, Kleiner Perkins Cau­field and Byers, Texas Pacific Group, Health­Cap, and Advanced Tech­nol­ogy Ventures.
#People #Financial #Website #More

FIVE PRIME THERAPEUTICS

Social Links:

facebook

Facebook

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Care Medical Therapeutics

Founded:
2001-01-01

Address:
San Francisco, California, United States

Country:
United States

Website Url:
http://www.fiveprime.com

Total Employee:
101+

Status:
Closed

Contact:
415-365-5600

Email Addresses:
[email protected]

Total Funding:
155.04 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 ReCAPTCHA Microsoft Azure DNS YouTube DoubleClick.Net ReCAPTCHA V2 Microsoft



Current Advisors List

lewis-williams_image

Lewis Williams Chairman of the Board of Directors @ Five Prime Therapeutics
Board_member

bruce-blazar_image

Bruce Blazar Member of the Scientific Advisors @ Five Prime Therapeutics
Advisor

not_available_image

Lee Douglas Member of the Board of Directors @ Five Prime Therapeutics
Board_member
2002-01-01

ronald-levy_image

Ronald Levy Member of the Scientific Advisors @ Five Prime Therapeutics
Advisor

joseph-goldstein_image

Joseph Goldstein Member of the Scientific Advisory Board @ Five Prime Therapeutics
Advisor
2002-07-01

daniel-hoff_image

Daniel Hoff Member of the Scientific Advisors @ Five Prime Therapeutics
Advisor

franklin-berger_image

Franklin Berger Member of the Board of Directors @ Five Prime Therapeutics
Board_member
2010-09-01

kapil-dhingra_image

Kapil Dhingra Member of the Board of Directors @ Five Prime Therapeutics
Board_member
2015-12-01

Current Employees Featured

lauretta-cesario_image

Lauretta Cesario
Lauretta Cesario Vice President, Human Resources @ Five Prime Therapeutics
Vice President, Human Resources
2009-08-01

michael-kavanaugh_image

Michael Kavanaugh
Michael Kavanaugh Senior Vice President and Chief Scientific Officer @ Five Prime Therapeutics
Senior Vice President and Chief Scientific Officer

thomas-civik_image

Thomas Civik
Thomas Civik President & Chief Executive Officer @ Five Prime Therapeutics
President & Chief Executive Officer
2020-04-01

jim-blair_image

Jim Blair
Jim Blair Director @ Five Prime Therapeutics
Director

lewis-williams_image

Lewis Williams
Lewis Williams Founder, President & CEO @ Five Prime Therapeutics
Founder, President & CEO
2011-08-01

kevin-p-baker_image

Kevin P. Baker
Kevin P. Baker Vice President, Preclinical Development @ Five Prime Therapeutics
Vice President, Preclinical Development
2006-01-01

david-v-smith_image

David V. Smith
David V. Smith Executive Vice President & Chief Financial Officer @ Five Prime Therapeutics
Executive Vice President & Chief Financial Officer
2018-11-01

robert-sikorski_image

Robert Sikorski
Robert Sikorski Vice President @ Five Prime Therapeutics
Vice President

Founder


lewis-williams_image

Lewis Williams

Stock Details


Company's stock symbol is NASDAQ:FPRX

Investors List

kleiner-perkins-caufield-byers_image

Kleiner Perkins

Kleiner Perkins investment in Private Equity Round - Five Prime Therapeutics

versant-ventures_image

Versant Ventures

Versant Ventures investment in Private Equity Round - Five Prime Therapeutics

pfizer-venture-investments_image

Pfizer Venture Investments

Pfizer Venture Investments investment in Venture Round - Five Prime Therapeutics

kleiner-perkins-caufield-byers_image

Kleiner Perkins

Kleiner Perkins investment in Venture Round - Five Prime Therapeutics

j-p-morgan-securities-inc_image

J.P. Morgan Securities Inc.

J.P. Morgan Securities Inc. investment in Venture Round - Five Prime Therapeutics

domain-associates_image

Domain Associates

Domain Associates investment in Venture Round - Five Prime Therapeutics

diamond-capital-company_image

Diamond Capital Company

Diamond Capital Company investment in Venture Round - Five Prime Therapeutics

wellcome-trust_image

Wellcome Trust

Wellcome Trust investment in Venture Round - Five Prime Therapeutics

singapore-bio-innovations_image

Singapore Bio-Innovations

Singapore Bio-Innovations investment in Venture Round - Five Prime Therapeutics

advanced-technology-ventures_image

Advanced Technology Ventures

Advanced Technology Ventures investment in Venture Round - Five Prime Therapeutics

Official Site Inspections

http://www.fiveprime.com

  • Host name: ewhserver1302.edgewebhosting.net
  • IP address: 69.63.140.80
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Five Prime Therapeutics"

Five Prime Therapeutics - Crunchbase Company Profile & Funding

FivePrime’s Pro­Screen Engine enables the rapid pro­duc­tion and screen­ing of all ther­a­peu­ti­cally. rel­e­vant pro­teins in medically- focused assays at the high­est qual­ity stan­dards in the indus­try. …See details»

Five Prime Therapeutics, Inc. - Dun & Bradstreet

Company Description: Five Prime Therapeutics is a clinical-stage biotechnology company that focuses on the development of immune modulators as well as precision therapies. Specifically …See details»

FivePrime Therapeutics - PitchBook

FivePrime Therapeutics was founded in 2001. Where is FivePrime Therapeutics headquartered? FivePrime Therapeutics is headquartered in South San Francisco, CA. What is the size of …See details»

Five Prime Therapeutics | DBL Partners

Five Prime Therapeutics 951 Gateway Boulevard South San Francisco, CA 94080 (650) 624-5900. www.fiveprime.comSee details»

Five Prime Therapeutics Appoints Tom Civik as Chief Executive …

Apr 14, 2020 Martin Forrest VP, Investor Relations & Corporate Communications Five Prime Therapeutics, Inc. 415-365-5625 [email protected] Release Summary Five Prime …See details»

Five Prime Corporate Overview - Seeking Alpha

Bemaritizumab in FGFR2b+ Gastric / Gastroesophageal Cancer • First-in-class selective FGFR2b antibody • BlocksFGFR2b activation by FGF7, 10 and 22 • Engineered to enhance tumor cell …See details»

FivePrime Therapeutics - VentureRadar

Using its integrated discovery platform, FivePrime is building a strong pipeline of oncology and immunology drug candidates. FivePrime mines its comprehensive library of secreted and …See details»

Five Prime Therapeutics - Overview, News & Similar companies

Jun 2, 2018 Who is Five Prime Therapeutics. Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of immuno-oncology …See details»

Five Prime Therapeutics, Inc. - San Francisco, USA - bionity.com

May 13, 2008 fiveprime.com +1415-365-5600. Share. Xing Linkedin Facebook X E-mail Loading... Bookmark. Bookmark list; Bookmark. Five Prime Therapeutics, Inc. 1650 Owens …See details»

Five Prime Therapeutics - Craft

Five Prime Therapeutics is a biotechnology company focused on developing immuno-oncology and targeted cancer therapies. Its product candidates include Bemarituzumab (FPA144), an …See details»

Amgen acquires Five Prime Therapeutics - 2021-03-04 - Crunchbase

Mar 4, 2021 Five Prime Therapeutics FivePrime is a clinical-stage biotechnology company that develops treatments for cancers. Acquiring Organization: Amgen Amgen is a biotechnology …See details»

Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash

Mar 4, 2021 THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., March 4, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Five Prime Therapeutics (NASDAQ: FPRX), …See details»

Development and Integration of a Fully Automated High …

Www.fiveprime.com | 9 Building vs. Buying a CLD Automation Platform Internal Resources –Automation Technologies Group »History of design and implementation of several large, high …See details»

Five Prime Therapeutics, Inc. (Five Prime Therapeutics, Inc.) - 药物 …

了解Five Prime Therapeutics, Inc. (Five Prime Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的15项临床试验, 47篇新闻和25篇文献，疾病领域:肿瘤，血液及淋巴系统疾 …See details»

Amgen to Acquire Five Prime Therapeutics for $1.9 Billion in Cash

Mar 4, 2021 Contacts. Amgen, Thousand Oaks Megan Fox, 805-447-1423 (media) Trish Rowland, 805-447-5631(media) Arvind Sood, 805-447-1060 (investors) Five Prime Media and …See details»

How Five Prime suitor Amgen battled multiple companies for the …

Mar 19, 2021 This midstage test enrolled 155 people with FGFR2b-positive tumors, a subpopulation that accounts for 30% of all non-HER2-positive patients, and randomized them …See details»

Bristol Myers Squibb - Bristol-Myers Squibb Enters into Exclusive ...

Oct 15, 2015 For more information, please visit www.fiveprime.com. Bristol-Myers Squibb Forward-Looking Statement. This press release contains “forward-looking statements” as that …See details»

Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash

Mar 4, 2021 THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., March 4, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Five Prime Therapeutics (NASDAQ: FPRX), …See details»

Prime time for Five Prime as Amgen snaps up this once-moribund …

Mar 4, 2021 After seeing the biotech's shares soar 300% late last year on positive new data for its midstage gastric cancer program, Amgen has stepped in with a $1.9 billion deal to buy out lSee details»

Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash

Mar 4, 2021 Amgen and Five Prime Therapeutics a clinical-stage biotechnology company focused on developing immuno-oncology and targeted cancer therapies, today announced an …See details»

linkstock.net © 2022. All rights reserved